GlassScriptPhysician profile
Olga A Tusheva
NPI 1124466859
$942.10
in general payments reported to CMS, 2019-2025
16 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $11.79 · 2021: $21.18 · 2022: $204 · 2023: $102 · 2024: $14.73 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $243.88 | 2019-2023 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $136.33 | 2022-2025 | |
| Shield Therapeutics INC | $85.10 | 2025 | |
| Evofem Biosciences, INC. | $83.65 | 2021-2022 | |
| Exeltis, USA INC. | $67.80 | 2022-2024 | Slynd |
| Scynexis, INC. | $49.78 | 2022 | |
| Astellas Pharma US INC | $45.04 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $42.85 | 2019 | |
| Therapeuticsmd, INC. | $39.02 | 2019 | |
| Mylan Pharmaceuticals INC. | $30.46 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.07 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $23.76 | 2025 | |
| Duchesnay USA Incorporated | $21.22 | 2019 | |
| Lupin INC. | $20.94 | 2019 | |
| Pfizer INC. | $13.41 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $11.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Tusheva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.